GlassScriptPhysician profile
Allison Elli Johnson
NPI 1982466934
$1,229.29
in general payments reported to CMS, 2019-2025
21 companies · $1,099 in 2025
The $1,099 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $130 · 2025: $1,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,129 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,129.30 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $414.81 | 2025 | Erleada, Rybrevant, Carvykti |
| Medtronic, INC. | $134.27 | 2025 | Interstim |
| Progenics Pharmaceuticals, INC. | $124.99 | 2025 | |
| Tempus Ai, INC | $96.42 | 2025 | Xt Cdx |
| Boston Scientific Corporation | $80.27 | 2025 | General - Kidney Stone Disease, Spaceoar Vue System - 10ml |
| Sun Pharmaceutical Industries INC. | $41.84 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $41.57 | 2025 | Keytruda, Welireg, Keytruda Qlex |
| Bayer Healthcare Pharmaceuticals INC. | $38.56 | 2024 | |
| Convatec INC. | $31.98 | 2024-2025 | |
| Abc Home Medical Supply, INC. | $29.19 | 2025 | |
| Eisai INC. | $22.75 | 2024 | |
| Amgen INC. | $21.20 | 2025 | Vectibix, Lumakras |
| Coloplast Corp | $19.45 | 2025 | |
| Tolmar, INC. | $18.20 | 2025 | Rubraca, Eligard |
| Pharmaand Gmbh | $18.20 | 2025 | Rubraca |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $17.05 | 2024 | Inspire |
| Astellas Pharma US INC | $16.74 | 2025 | Padcev |
| Illumina, INC. | $16.06 | 2025 | Oncology Testing |
| Novartis Pharmaceuticals Corporation | $15.46 | 2024 | |
| Abbvie INC. | $15.44 | 2025 | |
| Karl Storz Endoscopy-America | $14.84 | 2025 | N.A. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.